GlassScriptPhysician profile
Katrin Minasian
NPI 1083193478
$967.00
in general payments reported to CMS, 2019-2025
10 companies · $516 in 2025
The $516 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $293 · 2024: $158 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $451.03 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $182.36 | 2025 | Breztri, Tezspire |
| Verona Pharma, INC. | $96.10 | 2025 | Ohtuvayre |
| Glaxosmithkline, LLC. | $64.46 | 2025 | Trelegy Ellipta, Nucala |
| Insmed, INC. | $51.02 | 2025 | Arikayce |
| United Therapeutics Corporation | $34.13 | 2025 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.80 | 2025 | Jascayd |
| Merck Sharp & Dohme LLC | $24.69 | 2025 | Winrevair |
| Electromed, INC. | $21.72 | 2025 | Smartvest |
| Philips North America LLC | $13.69 | 2025 | Incourage Airway Clearance Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrin Minasian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.